Premo Partner Co., Ltd. 's medical device-focused acceleration program, "MedTech Angels Season 5," held its Demo Day on May 21, 2026, in Nihonbashi, Tokyo, where we received the top prize.
Building on this award, we will strongly promote the commercialization of angiogenesis therapy using ICS for severe lower limb ischemia.
We have been selected for the Direct Flight " San Diego Biotech Week Program supported by KBIC," a program promoted by MEDISO (Ministry of Health, Labour and Welfare's Total Support Project for Medical Ventures) to promote the overseas expansion of medical startups .
Using this program as a springboard, we will accelerate the overseas expansion of angiogenesis therapy using ICS for critical lower limb ischemia.
At the 25th Annual Meeting of the Japanese Society for Regenerative Medicine, held from March 19th to 20th , our CEO, Kenichi Yamahara, presented on comprehensive angiogenesis therapy for severe chronic lower limb ischemia (CLTI) using ICS-001, which is currently undergoing clinical trials. Furthermore, this technology was also presented at the 8th Regenerative Medicine Industry-Academia Collaboration Technology Auction.